The Commission has restricted the use of the chemicals N,N-dimethylacetamide (DMAC) and 1-ethylpyrrolidin-2-one (NEP) to protect workers from exposure to these substances. DMAC and NEP are solvents used in many industrial processes, including the production of chemicals, coatings, cleaning agents and fibres. DMAC is commonly used to manufacture synthetic fibres and varnishes for electrical cables, […]
Read More
Commission invests in innovative products against respiratory viruses
The European Commission, with the support of the European Investment Bank, will provide €20 million for the development of nasal sprays designed to protect against respiratory viruses. To this end, the Commission, through its Health Emergency Response and Preparedness Authority (HERA), has signed an investment agreement with Dutch biotech company Leyden Labs. Nasal sprays deliver […]
Read More
European Commission welcomes opening of new EU-funded University Hospital in Melilla
On the 2nd, the President of the Spanish Government, Pedro Sánchez, together with the President of the Autonomous City of Melilla, Juan José Imbroda, and the Minister of Health of the Spanish Government, Mónica García, inaugurated the new University Hospital of Melilla. Irina Vasiliu, a political analyst, attended the event on behalf of the European […]
Read More
European Week Against Cancer: providing patients with high-quality healthcare
Each and every EU citizen deserves the very best in cancer care. As it is marked the European Week Against Cancer (25-31 May), the European Commission reaffirms its commitment to achieve a European health union that delivers high-quality healthcare for all. Already through its Europe’s Beating Cancer Plan, the Commission has provided support to millions of people […]
Read More
Could we live without pain?
“There are people who live without pain,” says Treede, a neurophysiologist at the University of Heidelberg. “They have been known to exist for centuries. Insensitivity to pain, known as analgesia, is thought to be caused by a group of rare genetic diseases. However, being immune to pain does not mean being immune to injury. For […]
Read More
EU pledges €3.4 billion to combat global malnutrition
Last March 27th, at the Nutrition for Growth (N4G) Summit in Paris, the European Commission announced a new pledge of €3.4 billion until 2027 to combat malnutrition globally. This commitment builds on the EU’s ongoing efforts to reduce all forms of malnutrition and drive progress in nutrition-related interventions worldwide. The EU’s investment will focus […]
Read More
Commission takes stock of the work of HERA to reinforce health security in the EU
Last March 26th, the Commission has published a report assessing the work of the Commission’s Health Emergency Preparedness and Response Authority (HERA) since its creation over three years ago. The report highlights HERA’s achievements in strengthening EU-level preparedness and response capacities, as well as taking on new tasks, such as addressing the supply chain aspects of […]
Read More
Bone metastasis from melanoma, new hopes
New research offers hope for better treatment of bone metastases in people with melanoma. A new study has revealed the main mechanism that causes osteocyte death in bone metastasis in melanoma, one of the most malignant types of skin cancer. This research, supported in part by the EU-funded projects ODE and 4-D nanoSCOPE, provides a […]
Read More
Artificial intelligence aids respiratory assistance
EU-backed researchers are harnessing deep and machine learning to improve the lives of people with respiratory diseases and help the doctors who treat them. The EU-funded AI4LUNGS project team is using artificial intelligence (AI) to revolutionise respiratory health. Its achievements will lead to faster and more accurate diagnoses resulting in more personalised treatment plans for […]
Read More